Drago Bratkovic

2.4k total citations
48 papers, 419 citations indexed

About

Drago Bratkovic is a scholar working on Physiology, Rheumatology and Molecular Biology. According to data from OpenAlex, Drago Bratkovic has authored 48 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 20 papers in Rheumatology and 17 papers in Molecular Biology. Recurrent topics in Drago Bratkovic's work include Lysosomal Storage Disorders Research (25 papers), Glycogen Storage Diseases and Myoclonus (18 papers) and Metabolism and Genetic Disorders (12 papers). Drago Bratkovic is often cited by papers focused on Lysosomal Storage Disorders Research (25 papers), Glycogen Storage Diseases and Myoclonus (18 papers) and Metabolism and Genetic Disorders (12 papers). Drago Bratkovic collaborates with scholars based in Australia, United States and United Kingdom. Drago Bratkovic's co-authors include David R. Thorburn, Jillian Nicholl, Elizabeth Thompson, Michel Tchan, Jan Liebelt, M. Richardson, Kathleen H. Cox, Christopher Barnett, Sharon Bain and Ajay Taranath and has published in prestigious journals such as The Lancet, Blood and Neurology.

In The Last Decade

Drago Bratkovic

41 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Drago Bratkovic Australia 14 200 157 131 87 70 48 419
Anke Schumann Germany 11 179 0.9× 75 0.5× 149 1.1× 64 0.7× 109 1.6× 32 379
Ayesha Ahmad United States 13 151 0.8× 85 0.5× 120 0.9× 108 1.2× 62 0.9× 37 392
Michal Inbar‐Feigenberg Canada 10 191 1.0× 111 0.7× 77 0.6× 113 1.3× 63 0.9× 30 419
İlyas Okur Türkiye 12 124 0.6× 136 0.9× 78 0.6× 46 0.5× 86 1.2× 62 372
Elisabeth Jameson United Kingdom 11 120 0.6× 185 1.2× 102 0.8× 49 0.6× 93 1.3× 22 402
Serap Sivri Türkiye 11 120 0.6× 145 0.9× 182 1.4× 43 0.5× 62 0.9× 53 342
Ee Shien Tan Singapore 12 158 0.8× 74 0.5× 121 0.9× 76 0.9× 36 0.5× 27 351
Yılmaz Yıldız Türkiye 11 149 0.7× 75 0.5× 120 0.9× 39 0.4× 47 0.7× 57 317
Hanneke A. Haijes Netherlands 12 262 1.3× 77 0.5× 183 1.4× 75 0.9× 53 0.8× 18 409
Roberta Taurisano Italy 14 174 0.9× 257 1.6× 58 0.4× 63 0.7× 107 1.5× 28 501

Countries citing papers authored by Drago Bratkovic

Since Specialization
Citations

This map shows the geographic impact of Drago Bratkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drago Bratkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drago Bratkovic more than expected).

Fields of papers citing papers by Drago Bratkovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drago Bratkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drago Bratkovic. The network helps show where Drago Bratkovic may publish in the future.

Co-authorship network of co-authors of Drago Bratkovic

This figure shows the co-authorship network connecting the top 25 collaborators of Drago Bratkovic. A scholar is included among the top collaborators of Drago Bratkovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drago Bratkovic. Drago Bratkovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nicholls, Kathy, Charles Denaro, Michel Tchan, et al.. (2024). Fabry‐specific treatment in Australia: time to align eligibility criteria with international best practices. Internal Medicine Journal. 54(6). 882–890.
4.
Muenzer, Joseph, Barbara K. Burton, Paul Harmatz, et al.. (2024). Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase‐ IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II. Journal of Inherited Metabolic Disease. 48(3). e12790–e12790. 1 indexed citations
5.
Byrne, Barry J., Benedikt Schoser, Priya S. Kishnani, et al.. (2023). Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). Journal of Neurology. 271(4). 1787–1801. 14 indexed citations
6.
Thompson, Susan, Arthavan Selvanathan, Cathryn M. Lewis, et al.. (2023). Treatment of HMG-CoA Lyase Deficiency—Longitudinal Data on Clinical and Nutritional Management of 10 Australian Cases. Nutrients. 15(3). 531–531. 3 indexed citations
7.
Rudd-Schmidt, Jesse A., Tahereh Noori, Vivien R. Sutton, et al.. (2022). Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1. Blood. 139(12). 1833–1849. 7 indexed citations
8.
Muenzer, Joseph, Barbara K. Burton, Paul Harmatz, et al.. (2022). Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II. Molecular Genetics and Metabolism. 137(1-2). 92–103. 8 indexed citations
9.
Muenzer, Joseph, Barbara K. Burton, Paul Harmatz, et al.. (2022). Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study. Molecular Genetics and Metabolism. 137(1-2). 127–139. 23 indexed citations
10.
Riley, Lisa G., Minal Menezes, Andrew Williams, et al.. (2021). FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children. Molecular Genetics and Metabolism. 135(1). 63–71. 15 indexed citations
11.
Barcia, Giulia, Benedetta Ruzzenente, Zahra Assouline, et al.. (2020). Biallelic <i>IARS2</i> mutations presenting as sideroblastic anemia. Haematologica. 106(4). 0–0. 6 indexed citations
12.
Byrne, Alicia B., Peer Arts, Steven W. Polyak, et al.. (2019). Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6. npj Genomic Medicine. 4(1). 28–28. 16 indexed citations
13.
Suganuma, H, Andrew J McPhee, Drago Bratkovic, Robert A. Gibson, & Chad Andersen. (2019). Serial fatty acid profiles in a preterm infant with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency. Pediatrics International. 61(4). 415–416. 1 indexed citations
14.
Bush, Douglas, Jill Lipsett, David Ketteridge, et al.. (2018). Neonatal Onset Interstitial Lung Disease as a Primary Presenting Manifestation of Mucopolysaccharidosis Type I. JIMD Reports. 43. 71–77. 10 indexed citations
15.
Sun, Jun, Jason Pinner, Zhihui Yan, et al.. (2016). Diaphragmatic Eventration in Sisters with Asparagine Synthetase Deficiency: A Novel Homozygous ASNS Mutation and Expanded Phenotype. JIMD Reports. 34. 1–9. 23 indexed citations
16.
Roberts, Rachel, et al.. (2016). Relationships Between Childhood Experiences and Adulthood Outcomes in Women with PKU: A Qualitative Analysis. JIMD Reports. 32. 41–49. 7 indexed citations
17.
Mordaunt, Dylan, Liam McIntyre, Drago Bratkovic, et al.. (2015). Presentation of m.3243A>G (MT‐TL1; tRNALeu) variant with focal neurology in infancy. American Journal of Medical Genetics Part A. 167(11). 2697–2701. 3 indexed citations
18.
19.
Byrne, Barry J., Richard J. Barohn, Bruce A. Barshop, et al.. (2013). POM-001 phase 1/2 study of BMN 701, GILT-tagged recombinant human (rh) GAA in late-onset Pompe disease: Initial experience in 22 patients. Molecular Genetics and Metabolism. 108(2). S28–S28. 1 indexed citations
20.
Talseth‐Palmer, Bente A., Nikola A. Bowden, Cliff Meldrum, et al.. (2009). A 1q44 deletion, paternal UPD of chromosome 2 and a deletion due to a complex translocation detected in children with abnormal phenotypes using new SNP array technology. Cytogenetic and Genome Research. 124(1). 94–101. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anke Schumann Breakdown of academic impact, for papers by Ayesha Ahmad Breakdown of academic impact, for papers by Michal Inbar‐Feigenberg Breakdown of academic impact, for papers by İlyas Okur Breakdown of academic impact, for papers by Elisabeth Jameson Breakdown of academic impact, for papers by Serap Sivri Breakdown of academic impact, for papers by Ee Shien Tan Breakdown of academic impact, for papers by Yılmaz Yıldız Breakdown of academic impact, for papers by Hanneke A. Haijes Breakdown of academic impact, for papers by Roberta Taurisano
Rankless by CCL
2026